Home Newsfeeds JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

IMV Initiates Restructuring Proceedings Under The CCAA To Complete The Review Of Its Strategic Alternatives

By Benzinga Newsdesk

May 1, 12:32 PM

IMV Inc. (the "Company" or "IMV") (NASDAQ:IMV, TSX:IMV), a clinical-stage biopharmaceutical Company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and

IMV

Analyst Ratings

Analyst Ratings For Bunge Global

By Benzinga Insights

April 3, 11:01 AM

During the last three months, 9 analysts shared their evaluations of Bunge Global (NYSE:BG), revealing diverse outlooks from…

Legal
News

10x Genomics Comments On Second UPC Preliminary Injunction Decision After UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString’s CosMx Products In Europe Remain In Full Effect

By Benzinga Newsdesk

October 10, 12:08 PM

10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction against NanoString

NSTG